Is the US prepared to deal with another pandemic or widespread health crisis?
Short answer: Better than in 2020, but still not where it needs to be.
What’s stronger now
Where the gaps remain
Bottom line for October 15, 2026: The U.S. has clearer playbooks, faster data pipelines, stronger high‑consequence pathogen care networks, and better‑defined countermeasure needs than it did pre‑COVID. But chronic challenges—fragmented authority and data‑sharing, uneven state/local capacity, workforce attrition, supply‑chain fragility, and eroded trust—mean preparedness is uneven and could falter under a rapid, large‑scale event without sustained investment and clearer governance.[1]
If helpful, I can tailor this to a specific scenario (for example: an airborne respiratory virus vs. a hemorrhagic fever) or to your state’s current readiness profile.
Citations (10)
- CDC Data Modernization Efforts Accelerate Nation’s Ability to Detect and Rapidly Respond to Health Threats | CDC Online Newsroom | CDC
Backs: “CDC also broadened access to routine lab feeds and dashboards that integrate respiratory virus data. These upgrades shorten detection-to-action time.”
- NETEC Launches Second Round of NSPS STAND Awards to Expand National Special Pathogen Preparedness | NETEC
Backs: “The National Special Pathogen System (coordinated by NETEC) continues to add and fund treatment centers and training, improving the country’s ability to safely care for patients with Ebola, novel influenzas, etc.”
- ASPR Releases Five-Year Plan to Strengthen Medical Countermeasure Preparedness | ASPR
Backs: “HHS/ASPR’s multiyear medical‑countermeasure plan (PHEMCE) lays out what it will take to keep vaccines, drugs, and diagnostics ready for high‑priority threats and identifies funding gaps—useful for Congress and agencies to target investments.”
- Secure Our Herds
Backs: “The federal response to H5N1 detections in U.S. dairy cattle has involved USDA, CDC, and FDA working together on testing, biosafety, and product safety—evidence of improved cross‑sector playbooks.”
- High Risk List | U.S. GAO
Backs: “GAO’s 2025 and 2026 updates say HHS has open recommendations on surveillance, testing strategy, modeling coordination, and stockpile coordination—signaling persistent seams across agencies and with states.”
- GAO-26-107610, PUBLIC HEALTH PREPAREDNESS: Experts Identified Actions to Improve Surveillance for Emerging Disease Threats
Backs: “CDC also notes that some data flows used during the COVID emergency are no longer authorized outside an emergency, complicating comprehensive situational awareness.”
- Joint external evaluation of the International Health Regulations (2005) core capacities of the United States of America: mission report, 18–25 September 2024
Backs: “WHO’s 2024 external evaluation of U.S. core capacities praised national‑level strengths but urged closing gaps at state, local, tribal, and territorial levels and tracking workforce declines—problems that advocacy groups say are worsened by funding instability.”
- Federal Preparedness Programs Support Health Departments | ASTHO
Backs: “Federal support for healthcare readiness (e.g., the Hospital Preparedness Program and related initiatives) exists, but states report uncertainty and flat funding that make it hard to maintain surge capability between crises.”
- 2025-2028 Draft Action Plan for Addressing Shortages of Medical Products and Critical Foods and Strengthening the Resilience of Medical Product and Critical Food Supply Chains | ASPE
Backs: “GAO urges stronger HHS coordination to prevent and manage shortages—critical in any fast‑moving outbreak.”
- Poll: Trust in Public Health Agencies and Vaccines Falls Amid Republican Skepticism | KFF
Backs: “Recent national surveys (KFF, Annenberg) find confidence in federal health agencies has slipped since 2023, which can slow uptake of guidance, vaccines, and treatments during emergencies.”